Regentatlantic Capital LLC Merck & Co., Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 137,803 shares of MRK stock, worth $13.7 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

137,803

Previous 136,251 1.14%

Holding current value

$13.7 Million

Previous $12.4 Million 4.46%

% of portfolio

0.35%

Previous 0.41%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $131,190 - $147,377	1,552 Added 1.14%	137,803 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $269,004 - $304,930	3,222 Added 2.42%	136,251 $12.4 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $52,045 - $58,339	708 Added 0.54%	133,029 $10.9 Million
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $386,192 - $483,755	5,343 Added 4.21%	132,321 $10.1 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $734,935 - $808,243	10,253 Added 8.78%	126,978 $9.54 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $674,624 - $746,203	9,595 Added 8.96%	116,725 $9.08 Million
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $59,150 - $69,673	-859 Reduced 0.8%	107,130 $8.26 Million
Q4 2020 Feb 04, 2021	BUY	$71.77 - $79.65 $1.23 Million - $1.37 Million	17,153 Added 18.88%	107,989 $8.83 Million
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $127,991 - $145,079	1,749 Added 1.96%	90,836 $7.54 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $973,204 - $1.11 Million	13,820 Added 18.36%	89,087 $6.89 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $1.25 Million - $1.73 Million	-19,672 Reduced 20.72%	75,267 $5.79 Million
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $81,769 - $92,267	-1,054 Reduced 1.1%	94,939 $8.64 Million
Q3 2019 Oct 22, 2019	SELL	$76.08 - $82.93 $231,511 - $252,355	-3,043 Reduced 3.07%	95,993 $8.08 Million
Q2 2019 Jul 23, 2019	BUY	$69.84 - $81.59 $232,427 - $271,531	3,328 Added 3.48%	99,036 $8.3 Million
Q1 2019 May 03, 2019	BUY	$69.58 - $79.36 $64,709 - $73,804	930 Added 0.98%	95,708 $7.96 Million
Q4 2018 Jan 30, 2019	BUY	$65.24 - $75.71 $1.5 Million - $1.74 Million	23,009 Added 32.06%	94,778 $7.24 Million
Q3 2018 Oct 30, 2018	BUY	$57.69 - $67.84 $90,400 - $106,305	1,567 Added 2.23%	71,769 $5.09 Million
Q2 2018 Jul 31, 2018	SELL	$50.83 - $59.72 $61,961 - $72,798	-1,219 Reduced 1.71%	70,202 $4.26 Million
Q1 2018 Apr 23, 2018	SELL	$50.96 - $59.23 $367,982 - $427,699	-7,221 Reduced 9.18%	71,421 $3.89 Million
Q4 2017 Jan 23, 2018	SELL	$51.62 - $61.64 $385,549 - $460,389	-7,469 Reduced 8.67%	78,642 $4.43 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $5.05 Million - $5.44 Million	86,111	86,111 $5.51 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Merck & Co., Inc. Transaction History